Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?

Shanshal, Mohammed

Shanshal, Mohammed.

J Drugs Dermatol ; 19(4): 436, 2020 04 01.

Article in English | MEDLINE | ID: covidwho-264238

Subject(s)

Coronavirus Infections/epidemiology; Dermatology; Pneumonia, Viral/epidemiology; Skin Diseases/therapy; Betacoronavirus; Biological Products/adverse effects; Biological Products/therapeutic use; COVID-19; Comorbidity; Disease Management; Humans; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/therapeutic use; Pandemics; Risk Factors; SARS-CoV-2

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Skin Diseases / Coronavirus Infections / Dermatology Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: J Drugs Dermatol Journal subject: Dermatology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links